Trump started working on a vaccine before we had a single case in the US?
94.5% efficacy rate in record time. While the democrats were trying to impeach him, Trump was saving lives.
Moderna Announces Progress in Prophylactic Vaccines Modality with CMV Vaccine Phase 2 Study Data Now Expected in Third Quarter 2020 and Expands Investment in This Core Modality with Three New Development Candidates
Moderna announces progress in prophylactic vaccines modality with CMV vaccine Phase 2 study data now expected in third quarter 2020.
www.businesswire.com
94.5% efficacy rate in record time. While the democrats were trying to impeach him, Trump was saving lives.